A
Aphea.Bio
Develops microbial-based biostimulant and biocontrol products using a high-throughput platform to protect crops while reducing chemical inputs
About Aphea.Bio
Aphea.Bio is a biotechnology startup that operates in the agricultural sector. The company focuses on the discovery and development of novel and unique strains of biologicals, with a proprietary collection of over 15,000 strains. These biologicals are used to create biocontrol and biostimulant products that help farmers maintain the health of their crops.
Read full description
The company's business model is based on the use of advanced technologies such as microbiome mapping and high-throughput analytical methods to identify beneficial plant-microbe interactions. These technologies allow Aphea.Bio to screen thousands of potential product candidates quickly and efficiently.
Once potential candidates are identified, the company uses in-house data mining capabilities and expertise to evaluate these leads. This process involves high-throughput, automated plant phenotyping and AI-based disease scoring algorithms. The goal is to identify the candidates that will make a significant difference for the plants and, ultimately, the farmers.
The company also has an experienced team of field trial managers and scientific experts who implement extensive field trial programs. These programs, combined with the company's in-house data management and statistics system, allow Aphea.Bio to perform in-depth analysis of their data and steer their development process effectively.
In terms of revenue, Aphea.Bio likely makes money by selling their biocontrol and biostimulant products to farmers and agricultural businesses. The company's unique approach and proprietary strains give it a competitive edge in the market, potentially allowing it to charge premium prices for its products.
At a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Ghent, Belgium
- Employees
- 67
- Open positions
- None listed
- Dealroom signal
- 66.0/100
- Sub-industry
- AgriTech
- Sector
- Food, Biotechnology, Crop Protection, Fertigation, Microbiology, Synthetic Biology, Spinout, Fertilizer, Primary Production, Sustainable Development Goals, Regenerative Agriculture
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Nov 2024 | $2.1M | — | VLAIO- Team Bedrijfstrajecten Crossroads France-Wallonie-Vlaanderen | ↗ |
| SERIES COther financing | Jul 2023 | $77M | $308M | Gemma Frisius Fund - GFF · Korys · SFPIM · V-Bio Ventures | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Aphea.Bio is 5K monthly website visits, up 117.4% over the last three months. Aphea.Bio's team declined 8.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Flanders Institute for Biotechnology
V-Bio Ventures
VLAIO- Team Bedrijfstrajecten Crossroads France-Wallonie-Vlaanderen
Series A7 investors entered at this stage
Qbic Fund
Vives Partners
Gemma Frisius Fund - GFF
Agri Investment Fund
Astanor Ventures
PMV
European Circular Bioeconomy Fund
Series B and later7 investors entered at this stage
Innovation Industries
Korys
SFPIM- QBQBicII
BNP Paribas
Bill & Melinda Gates Foundation
Vanden Avenne Commodities
Other known investors2 additional known investors
Ghent University
KU Leuven
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aphea.Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aphea.Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.